Gene therapy using stem cells

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 4, 2015, Pages

  Burnight, Erin R ^a   Wiley, Luke A ^a   Mullins, Robert F ^a   Stone, Edwin M ^a,b   Tucker, Budd A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; GENE TARGETING; GENE TRANSFER; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; STEM CELL GENE THERAPY; ANIMAL; CYTOLOGY; DEPENDOPARVOVIRUS; DISEASE MODEL; GENE THERAPY; GENE VECTOR; GENETICS; PIG; PROCEDURES; RETINAL DEGENERATION; STEM CELL; STEM CELL TRANSPLANTATION; VIROLOGY;

ANIMALIA;

ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENETIC THERAPY; GENETIC VECTORS; HUMANS; RETINAL DEGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; SWINE;

EID: 84926335826     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017434     Document Type: Article

References (77)

1. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, et al. 2001. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28: 92- 95.
2. Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, et al. 2005. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12: 1072-1082.
3. Asuri P, Bartel MA, Vazin T, Jang J-H, Wong TB, Schaffer DV. 2012. Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells. Mol Ther 20: 329-338.
4. Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, et al. 2008. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 358: 2231-2239.
5. Balaggan KS, Ali RR. 2012. Ocular gene delivery using lentiviral vectors. Gene Ther 19: 145-153.
6. Bemelmans A-P, Kostic C, Cachafeiro M, Crippa SV, Wanner D, Tekaya M, Wenzel A, Arsenijevic Y. 2008. Lentiviral gene transfer-mediated cone vision restoration in RPE65 knockout mice. Adv Exp Med Biol 613: 89-95.
7. Bennicelli J, Wright JF, Komaromy A, Jacobs JB, Hauck B, Zelenaia O, Mingozzi F, Hui D, Chung D, Rex TS, et al. 2008. Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther 16: 458-465.
8. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1512.
9. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R. 2008. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151-159.
10. Burnight ER, Wiley LA, Drack AV, Braun TA, Anfinson KR, Kaalberg EE, Halder JA, Affatigato LM, Mullins RF, Stone EM, et al. 2014. CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype. Gene Ther 21: 662-672.
11. Calame M, Cachafeiro M, Philippe S, Schouwey K, Tekaya M, Wanner D, Sarkis C, Kostic C, Arsenijevic Y. 2011. Retinal degeneration progression changes lentiviral vector cell targeting in the retina. PLoS ONE 6: e23782.
12. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R. 2009. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci 106: 157-162.
13. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, et al. 2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
14. Chang B, Khanna H, Hawes N, Jimeno D, He S, Lillo C, Parapuram SK, Cheng H, Scott A, Hurd RE, et al. 2006. In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet 15: 1847-1857.
15. Cho SW, Kim S, Kim JM, Kim J-S. 2013. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-232.
16. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
17. Conlon TJ, Deng W-T, Erger K, Cossette T, Pang J-J, Ryals R, Clément N, Cleaver B, McDoom I, Boye SE, et al. 2013. Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev 24: 23-28.
18. Dai X, Han J, Qi Y, Zhang H, Xiang L, Lv J, Li J, Deng W-T, Chang B, Hauswirth WW, et al. 2014. AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice. Invest Ophthalmol Vis Sci 55: 1724-1734.
19. Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD, Holmes MC. 2011. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 8: 74-79.
20. Ellis J. 2005. Silencing and variegation of g retrovirus and lentivirus vectors. Hum Gene Ther 16: 1241-1246.
21. Endo M, Zoltick PW, Chung DC, Bennett J, Radu A, Muvarak N, Flake AW. 2007. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 15: 579-587.
22. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826.
23. Gaspar HB, Cooray S, Gilmour KC, Parsley KL, Zhang F, Adams S, Bjorkegren E, Bayford J, Brown L, Davies EG, et al. 2011. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 3: p97ra80.
24. González F, Barragan Monasterio M, Tiscornia G, Montserrat Pulido N, Vassena R, Batlle Morera L, Rodríguez-Pizà I, Izpisúa Belmonte JC. 2009. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci 106: 8918-8922.
25. Gu K, Yang B, Tian D, Wu L, Wang D, Sreekala C, Yang F, Chu Z, Wang G-L, White FF, et al. 2005. R gene expression induced by a type-III effector triggers disease resistance in rice. Nature 435: 1122-1125.
26. Hacein-Bey-Abina S, Kalle Von C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
27. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, et al. 2008. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum Gene Ther 19: 979-990.
28. Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O, Dieter SM, Fessler S, van der Hoeven F, Kloz U, et al. 2012. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 20: 1014-1021.
29. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, et al. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29: 731-734.
30. Homma K, Okamoto S, Mandai M, Gotoh N, Rajasimha HK, Chang Y-S, Chen S, Li W, Cogliati T, Swaroop A, et al. 2013. Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors. Stem Cells 31: 1149-1159.
31. Hu K. 2014. All roads lead to induced pluripotent stem cells: The technologies of iPSC generation. Stem Cells Dev 23: 1285-1300.
32. Ikeda Y, Yonemitsu Y, Sakamoto T, Ishibashi T, Ueno H, Kato A, Nagai Y, Fukumura M, Inomata H, Hasegawa M, et al. 2002. Recombinant Sendai virus-mediated gene transfer into adult rat retinal tissue: Efficient gene transfer by brief exposure. Exp Eye Res 75: 39-48.
33. Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno R-I, Murakami Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, et al. 2009. Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors. Hum Gene Ther 20: 573-579.
34. Jin Z-B, Okamoto S, Xiang P, Takahashi M. 2012. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Transl Med 1: 503-509.
35. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. 2013. RNA-programmed genome editing in human cells. eLife 2: e00471.
36. Kay S, Hahn S, Marois E, Hause G, Bonas U. 2007. A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science 318: 648-651.
37. Kim KS, Lee HJ, Jeong HS, Li J, Teng YD, Sidman RL, Snyder EY, Kim SU. 2011. Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell. Proc Natl Acad Sci 108: 4876-4881.
38. Koirala A, Conley SM, Makkia R, Liu Z, Cooper MJ, Sparrow JR, Naash MI. 2013. Persistence of non-viral vector mediated RPE65 expression: Case for viability as a gene transfer therapy for RPE-based diseases. J Control Release 172: 745-752.
39. Lamba DA, Gust J, Reh TA. 2009. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 4: 73-79.
40. Lamba DA, McUsic A, Hirata RK, Wang P-R, Russell D, Reh TA. 2010. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS ONE 5: e8763.
41. Li Q, Miller R, Han P-Y, Pang J, Dinculescu A, Chiodo V, Hauswirth WW. 2008. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis 14: 1760-1769.
42. Lindahl T. 1993. Instability and decay of the primary structure of DNA. Nature 362: 709-715.
43. Liu H, Ye Z, Kim Y, Sharkis S, Jang Y-Y. 2010. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51: 1810- 1819.
44. Loh Y-H, Agarwal S, Park I-H, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ. 2009. Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479.
45. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, et al. 2008. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 358: 2240-2248.
46. Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying G-S, Rossi S, et al. 2009. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: A phase 1 dose-escalation trial. Lancet 374: 1597-1605.
47. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K. 2008. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340-345.
48. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
49. Malik N, Rao MS. 2013. A review of the methods for human iPSC derivation. Methods Mol Biol 997: 23-33.
50. Molday LL, Djajadi H, Yan P, Szczygiel L, Boye SL, Chiodo VA, Gregory-Evans K, Sarunic MV, Hauswirth WW, Molday RS. 2013. RD3 gene delivery restores guanylate cyclase localization and rescues photoreceptors in the Rd3 mouse model of Leber congenital amaurosis 12. Hum Mol Genet 22: 3894-3905.
51. Moscou MJ, Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501.
52. Narfström K, Katz ML, Bragadottir R, Seeliger M, Boulanger A, Redmond TM, Caro L, Lai C-M, Rakoczy PE. 2003. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci 44: 1663-1672.
53. Nicoud M, Kong J, Iqball S, Kan O, Naylor S, Gouras P, Allikmets R, Binley K. 2007. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors. J Gene Med 9: 1015-1023.
54. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee Y-L, et al. 2008. Establishment of HIV-1 resistance in CD4þ T cells by ge nome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816.
55. Preynat-Seauve O, de Rham C, Tirefort D, Ferrari-Lacraz S, Krause K-H, Villard J. 2009. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic Tand natural killer cells. J Cell Mol Med 13: 3556- 3569.
56. Ramalingam S, Kandavelou K, Rajenderan R, Chandrasegaran S. 2011. Creating designed zinc-finger nucleases with minimal cytotoxicity. J Mol Biol 405: 630-641.
57. Ran FA, Hsu PD, Lin C-Y, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, et al. 2013a. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380- 1389.
58. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. 2013b. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8: 2281-2308.
59. Raya A, Rodríguez-Pizà I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castellà M, Río P, Sleep E, et al. 2009. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460: 53-59.
60. Reichel MB, Ali RR, Thrasher AJ, Hunt DM, Bhattacharya SS, Baker D. 1998. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther 5: 1038-1046.
61. Ross JW, Fernandez de Castro JP, Zhao J, Samuel M, Walters E, Rios C, Bray-Ward P, Jones BW, Marc RE, Wang W, et al. 2012. Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 53: 501- 507.
62. Schornack S, Meyer A, Römer P, Jordan T, Lahaye T. 2006. Gene-for-gene-mediated recognition of nuclear-targeted AvrBs3-like bacterial effector proteins. J Plant Physiol 163: 256-272.
63. Seo S, Mulins RF, Dumitrescu AV, Bhattarai S, Gratie D, Wang K, Stone E, Sheffield VC, Drack AV. 2013. Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1. Invest Ophthalmol Vis Sci 54: 6118-6132.
64. Si-Tayeb K, Noto FK, Sepac A, Sedlic F, Bosnjak ZJ, Lough JW, Duncan SA. 2010. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol 10: 81.
65. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. 2008. Induced pluripotent stem cells generated without viral integration. Science 322: 945-949.
66. Sugio A, Yang B, Zhu T, White FF. 2007. Two type III effector genes of Xanthomonas oryzae pv. oryzae control the in duction of the host genes OsTFIIAg1 and OsTFX1 during bacterial blight of rice. Proc Natl Acad Sci 104: 10720- 10725.
67. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
68. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
69. Testa F, Maguire AM, Rossi S, Pierce EA, Melillo P, Marshall K, Banfi S, Surace EM, Sun J, Acerra C, et al. 2013. Threeyear follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2. Ophthalmology 120: 1283-1291.
70. Tucker BA, Scheetz TE, Mullins RF, DeLuca AP, Hoffmann JM, Johnston RM, Jacobson SG, Sheffield VC, Stone EM. 2011. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci 108: E569-E576.
71. Tucker BA, Anfinson KR, Mullins RF, Stone EM, Young MJ. 2013a. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med 2: 16-24.
72. Tucker BA, Mullins RF, Streb LM, Anfinson K, Eyestone ME, Kaalberg E, Riker MJ, Drack AV, Braun TA, Stone EM. 2013b. Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. eLife 2: e00824.
73. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/ Cas-mediated genome engineering. Cell 153: 910-918.
74. West EL, Pearson RA, Barker SE, Luhmann UFO, Maclaren RE, Barber AC, Duran Y, Smith AJ, Sowden JC, Ali RR. 2010. Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 28: 1997-2007.
75. Wu Z, Yang H, Colosi P. 2010. Effect of genome size on AAV vector packaging. Mol Ther 18: 80-86.
76. Wu G, Liu N, Rittelmeyer I, Sharma AD, Sgodda M, Zaehres H, Bleidissel M, Greber B, Gentile L, Han DW, et al. 2011. Generation of healthy mice from gene-corrected diseasespecific induced pluripotent stem cells. PLoS Biol 9: e1001099.
77. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.